Answers are grounded in this paper and cite their sources.
We report a novel strategy to enzymatically release affinity-selected cells, such as circulating tumor cells (CTCs), from surfaces with high efficiency (∼90%) while maintaining cell viability (>85%). The strategy utilizes single-stranded DNAs that link a capture antibody to the surfaces of a CTC selection device. The DNA linkers contain a uracil residue that can be cleaved.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: